Reply to Schramm, L. Comment on "Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364"
Diagnostics (Basel). 2022 Mar 2;12(3):617.
doi: 10.3390/diagnostics12030617.
1 Department of Oncology, The People's Hospital of Bishan District, Chongqing 402760, China.
2 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.
3 Department of Otolaryngology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
4 Department of Oral and Maxillofacial Surgery, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai 519000, China.
5 Department of Health Management, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, Zhuhai 519000, China.
6 Neuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, CHOC Children's Research Institute, Children's Hospital of Orange County (CHOC), 1201 West La Veta Ave., Orange, CA 92868-3874, USA.
7 Department of Neurology, Irvine School of Medicine, University of California, 200 S Manchester Ave. Ste. 206, Orange, CA 92868, USA.